Resources for professionals
Ondansetron: click here to read the Irish Medicines in Pregnancy Service (IMPS) statement on ondansetron in pregnancy (2019).
The 2024 MBRRACE report (covering 2020-2022 in the UK & Ireland) highlights the importance of prompt recognition and treatment of thrombosis and thromboembolism, as the leading cause of death in pregnancy and postpartum. Women with HG are at higher risk of VTE due to dehydration and immobilisation, and their risk profile should be dynamically assessed throughout pregnancy. Please see the full report for case studies and recommendations.
Click here for a printable information leaflet about tips for eating and drinking
The National Medicines Information Centre factsheet on medications and breastfeeding